Breaking News on Global Pharmaceutical Technology & Manufacturing

Delivery technologies


Watch now!On-Demand Supplier Webinar

BASF Pharma Solutions for Dermal Drug Delivery - BASF SE

03-Jun-2014 - Transdermal drug delivery is an exciting and challenging area. How can skin permeation be improved? What is the key to drug solubilization in transdermal delivery systems? BASF's Skin Delivery platform seeks to provide understanding, solutions and materials for the delivery...
Download now!Technical / white paper

Bioequivalence for Nasal Sprays : Importance of Device Performance - Rexam Healthcare

26-May-2014 - Because the efficacy of the drug depends upon the spray device’s ability to deliver a uniform dose as well as a reproducible droplet size and plume, the delivery system is a critical element for nasal spray performance. Rexam has established...
Download now!Technical / white paper

Smart strategies for sustained release matrix tablets: Compritol® 888 ATO - Gattefossé Pharma

19-May-2014 - This white paper gives an overview of how Compritol® 888 ATO provides clinically relevant sustained drug release profiles along with biopharmaceutical, formulation and manufacturing advantages.We provide an insight on formulation critical attributes, how Compritol® can be used in a range...
Download now!Press release

CREMER OLEO has become the holder of the first CEP ever granted for a Medium-Chain Triglyceride (MIGLYOL® 812 N). - CREMER OLEO GmbH & Co. KG

28-Apr-2014 - CREMER OLEO has gathered its activities for the pharmaceutical industry under the roof of CREMER Health, with a strong commitment to quality leadership in Oleoceuticals. Our pharmaceutical excipients for topical, oral and rectal applications as well as our oleo-chemical based active...
Access now!Information request

Maximize Excipient Purity to Optimize Efficacy - Croda

14-Apr-2014 - The purity of your excipient can have a profound impact on your formulation’s performance, affecting both the stability of the drug and the final formulation.  Croda’s Super Refined™ range offers the most highly-purified excipients available, providing the power of purity...
Watch now!On-Demand Supplier Webinar

How glass-forming polymers improve bioavailability / Enhanced oral bioavailability with Soluplus® – case study - BASF SE

26-Mar-2014 - How glass-forming polymers improve bioavailabilityPolymers are essential components of oral solid dosage forms and used as binders, disintegrants or coatings. Given the increase in poorly water-soluble drugs, not only well-known but also specifically designed polymers (e.g. Soluplus®) can be used...
Download now!Case study

Film Coating for Taste-masking of an HIV Drug for Pediatrics - Colorcon

25-Mar-2014 - MSD evaluated several taste-masking options to coat raltegravir granules, for pediatric dosing.  They chose a coating comprised of Surelease®, aqueous ethylcellulose dispersion, in combination with an Opadry® product.  Insoluble in water, ethylcellulose acts as the taste-masking agent by delaying the...
Watch now!On-Demand Supplier Webinar

Dow AFFINISOL™ polymers for Solubility Enhancement - Dow Pharma & Food Solutions

12-Mar-2014 - Dow’s AFFINISOL™ line of excipients include AFFINISOL™ HMPCAS for spray drying applications and AFFINISOL™ HPMC for hot melt extrusion (HME) applications. Hypromellose acetate succinate (HPMCAS) has proven effective at producing stable amorphous solid dispersions for poorly soluble APIs. We will highlight: •...
Watch now!On-Demand Supplier Webinar

Role of excipients in design of solid amorphous drug dispersions for delivery of poorly water-soluble drugs - Ashland

10-Mar-2014 - Most new drug candidates suffer from poor water- solubility leading to rate limiting dissolution, slow absorption and limited bioavailability. Solid amorphous drug dispersions are most commonly used improve bioavailability by enhancing drug solubility. The selection of the right solid dispersion...
Watch now!On-Demand Supplier Webinar

Bioavailability Enhancement Series: Hot-Melt Extrusion - Capsugel

18-Feb-2014 - Hot-melt extrusion (HME) of amorphous solid dispersions is one approach Bend Research uses to address APIs with limited bioavailability due to low solubility and dissolution rates (DCS IIa and IIb). Please join us to discuss solid dispersion formulation selection and...
Download now!Technical / white paper

Film Coating for Pediatric Oral Solid Dosage Forms - Colorcon

14-Jan-2014 - With careful selection, of an appropriate film coating system, pediatric products may be coated with a suitable color while also providing mechanical integrity, gloss and moisture protection to produce a robust tablet that is effective and easily recognized by consumers...
Watch now!On-Demand Supplier Webinar

New Developments in Controlled Nucleation during Lyophilization - IMA LIFE

08-Jan-2014 - For the past few years, controlled nucleation during the freeze drying process has been a subject of great interest to the bio-pharm community. The potential benefits of enhanced process control, process repeatability, and cycle time reduction are exciting to both...
Watch now!On-Demand Supplier Webinar

Bioavailability Enhancement Series – Nanoparticle Dispersions & Drug Nanocyrstals - Capsugel

06-Jan-2014 - Drug-containing nanoparticles offer the potential for both increased dissolution rate and higher drug activity compared to bulk crystalline drug.  These advantages can improve oral bioavailability of drugs for which absorption is either dissolution-rate-limited (i.e. DCS Class IIa), or solubility-limited (i.e.,...
Download now!Application note

With Advancia® get the dose right every time! - Rexam Healthcare

02-Dec-2013 - The intranasal route is widely used for both prescription and over-the-counter drugs, as well as for medical devices (saline solutions). Indeed, it is an attractive option for locally acting drugs or systemically acting drugs, as it offers rapid onset of...
Watch now!On-Demand Supplier Webinar

Bioavailability Enhancement: Amorphous Solid Dispersion Formulations Using the Spray Dry - Capsugel

05-Nov-2013 - Amorphous solid dispersion technology has been developed to be a preferred formulation option to improve solubility and dissolution rate of insoluble compounds with a wide range of applicability. When amorphous compounds are delivered orally, their solubility advantage can translate into...
Download now!Technical / white paper

NEOBEE® MCTs Enhance Pharmaceutical Bioavailability - Stepan Lipid Nutrition

04-Nov-2013 - An efficient solvent for many lipophylic drugs and vitamins, NEOBEE® MCTs emulsify in aqueous environments and help uptake in intestinal cells. They are odorless, tasteless and extremely stable and offer a safe, versatile, affordable and simple solution for many bioavailability...
Watch now!On-Demand Supplier Webinar

New Guidelines for Stabilization of Proteins by Freeze Drying: Formulation and Process Heresy - Baxter

17-Oct-2013 - Over the years a number of informal guidelines or “rules” for the formulation and processing of proteins for freeze-drying have been developed. However, in recent years it has become obvious that some of these rules need modification. In this presentation,...
Download now!Technical / white paper

Applying disruptive technologies in mammalian cell line development - Fujifilm

14-Oct-2013 - Biopharmaceutical manufacturers traditionally rely on cell line development (CLD) “platforms” which combine long development timelines with unpredictable and extensive variation. In this review, we describe the current status of CLD and describe emerging technologies which offer the potential of greater...
Download now!Data sheet

Inhalia®. Designed to deliver a consistent dose, every time! - Rexam Healthcare

23-Sep-2013 - Rexam’s precision metering valve platform for pressurized-metered dose inhalers (pMDIs) Inhalia® meets a wide range of requirements and is ideal for all patients, even with infrequent treatment needs, due to its long prime retention, very low leakage and moisture ingress....
Download now!Technical / white paper

Nucleic Acid Amplification Technique for Biosafety - SGS Life Science Services

09-Sep-2013 - Use of cutting-edge NATs reduces the amount of time needed for development and safety testing of novel biotech products. This white paper describes specific NAT applications including the detection of contaminating viruses, mycoplasma & mycobacteria.

Related News

Key Industry Events


Access all events listing

Our events, Events from partners...

Product Innovation